MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.
Hepatic steatosis is a global epidemic that is thought to contribute to the pathogenesis of type 2 diabetes. MicroRNAs (miRs) are regulators that can functionally integrate a range of metabolic and inflammatory pathways in liver. We aimed to investigate the functional role of miR-155 in hepatic stea...
Guardado en:
Autores principales: | Ashley M Miller, Derek S Gilchrist, Jagtar Nijjar, Elisa Araldi, Cristina M Ramirez, Christopher A Lavery, Carlos Fernández-Hernando, Iain B McInnes, Mariola Kurowska-Stolarska |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8508583358914a5dae77f177289ea05d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis
por: Stefano Alivernini, et al.
Publicado: (2016) -
Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium
por: Ingrid Gomez, et al.
Publicado: (2020) -
Acta No. 155
por: Banco Central de Chile
Publicado: (2019) -
miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression.
por: Heiko F Stahl, et al.
Publicado: (2009) -
Identification of Small Molecule Inhibitors of a Mir155 Transcriptional Reporter in Th17 Cells
por: Anju Singh, et al.
Publicado: (2021)